Filing Details
- Accession Number:
- 0001237899-20-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-22 16:31:48
- Reporting Period:
- 2020-07-20
- Accepted Time:
- 2020-07-22 16:31:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697422 | R. Christopher Fenimore | 777 Old Saw Mill River Road Tarrytown NY 10591 | Vp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-20 | 10,000 | $179.13 | 25,277 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-20 | 6,291 | $655.57 | 18,986 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2020-07-20 | 2,224 | $52.03 | 21,210 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-21 | 216 | $636.56 | 20,994 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 154 | $637.88 | 20,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 306 | $638.51 | 20,534 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 75 | $639.64 | 20,459 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 113 | $640.61 | 20,346 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 855 | $641.58 | 19,491 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 676 | $642.39 | 18,815 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 691 | $643.49 | 18,124 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 303 | $644.57 | 17,821 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 72 | $645.33 | 17,749 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 155 | $646.82 | 17,594 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 82 | $647.79 | 17,512 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-21 | 11 | $658.00 | 17,501 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2020-07-20 | 2,224 | $0.00 | 2,224 | $52.03 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-07-20 | 10,000 | $0.00 | 10,000 | $179.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-12-16 | No | 4 | M | Direct | |
| 13,500 | 2022-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,432 | Indirect | By 401(k) Plan |
| Common Stock | 1,897 | Indirect | By Trust |
| Common Stock | 509 | Indirect | by 2017 GRAT |
| Common Stock | 2,284 | Indirect | by 2018 GRAT |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 216 shares of Company stock on July 21, 2020 at prices ranging from $636.56 to $636.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price.
- Represents volume-weighted average price of sales of 154 shares of Company stock on July 21, 2020 at prices ranging from $637.79 to $637.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price.
- Represents volume-weighted average price of sales of 306 shares of Company stock on July 21, 2020 at prices ranging from $638.44 to $638.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price.
- Represents volume-weighted average price of sales of 75 shares of Company stock on July 21, 2020 at prices ranging from $639.22 to $639.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price.
- Represents volume-weighted average price of sales of 855 shares of Company stock on July 21, 2020 at prices ranging from $641.00 to $641.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price.
- Represents volume-weighted average price of sales of 676 shares of Company stock on July 21, 2020 at prices ranging from $642.25 to $642.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price.
- Represents volume-weighted average price of sales of 691 shares of Company stock on July 21, 2020 at prices ranging from $643.00 to $643.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price.
- Represents volume-weighted average price of sales of 303 shares of Company stock on July 21, 2020 at prices ranging from $644.32 to $644.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price.
- Represents volume-weighted average price of sales of 155 shares of Company stock on July 21, 2020 at prices ranging from $646.71 to $646.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price.
- These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
